The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2020

Filed:

Aug. 02, 2017
Applicant:

Codex Dna, Inc., San Diego, CA (US);

Inventors:

Daniel G. Gibson, Carlsbad, CA (US);

Nicky Caiazza, Rancho Santa Fe, CA (US);

Toby H. Richardson, San Diego, CA (US);

Assignee:

Codex DNA, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 19/34 (2006.01); C12Q 1/68 (2018.01); C12N 15/10 (2006.01); C12N 9/22 (2006.01); C12Q 1/6844 (2018.01);
U.S. Cl.
CPC ...
C12N 15/1093 (2013.01); C12N 9/22 (2013.01); C12P 19/34 (2013.01); C12Q 1/6844 (2013.01); C12Y 301/11 (2013.01); C12Y 301/21 (2013.01); C07K 2319/00 (2013.01); C07K 2319/036 (2013.01); C07K 2319/21 (2013.01);
Abstract

The present invention provides materials and methods useful for error correction of nucleic acid molecules. In one embodiment of the invention, a first plurality of double-stranded nucleic acid molecules having a nucleotide mismatch are fragmented by exposure to a molecule having unidirectional mismatch endonuclease activity. The nucleic acid molecules are cut at the mismatch site or near the mismatch site, leaving a double-stranded nucleic acid molecule having a mismatch at the end or near end of the molecule. The nucleic acid molecule is then exposed to a molecule having unidirectional exonuclease activity to remove the mismatched nucleotide. The missing nucleotides can then be filled in by the action of, e.g., a molecule having DNA polymerase activity. The result is double-stranded nucleic acid molecules with a decreased frequency of nucleotide mismatches. Also provided are novel nucleic acid sequences encoding mismatch endonucleases, polypeptides encoded thereby, as well as nucleic acid constructs, transgenic cells, and various compositions thereof.


Find Patent Forward Citations

Loading…